| Title |
Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism
|
|---|---|
| Published in |
Cochrane database of systematic reviews, July 2013
|
| DOI | 10.1002/14651858.cd003074.pub3 |
| Pubmed ID | |
| Authors |
Sherab Bhutia, Peng F Wong |
| Abstract |
In the initial treatment of venous thromboembolism (VTE) low molecular weight heparin (LMWH) is administered once or twice daily. A once daily treatment regimen is more convenient for the patient and may optimise home treatment. However, it is not clear whether a once daily treatment regimen is as safe and effective as a twice daily treatment regimen. This is the second update of a review first published in 2003. |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 40% |
| Spain | 3 | 30% |
| United Kingdom | 1 | 10% |
| Grenada | 1 | 10% |
| Unknown | 1 | 10% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 70% |
| Practitioners (doctors, other healthcare professionals) | 2 | 20% |
| Scientists | 1 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 126 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Denmark | 1 | <1% |
| Argentina | 1 | <1% |
| Egypt | 1 | <1% |
| Unknown | 123 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 16 | 13% |
| Researcher | 15 | 12% |
| Student > Bachelor | 13 | 10% |
| Student > Postgraduate | 12 | 10% |
| Student > Ph. D. Student | 11 | 9% |
| Other | 28 | 22% |
| Unknown | 31 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 63 | 50% |
| Nursing and Health Professions | 10 | 8% |
| Agricultural and Biological Sciences | 4 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 2% |
| Psychology | 3 | 2% |
| Other | 9 | 7% |
| Unknown | 34 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 June 2020.
All research outputs
#5,161,236
of 24,631,014 outputs
Outputs from Cochrane database of systematic reviews
#7,574
of 12,951 outputs
Outputs of similar age
#41,328
of 198,824 outputs
Outputs of similar age from Cochrane database of systematic reviews
#176
of 302 outputs
Altmetric has tracked 24,631,014 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,951 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.9. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 198,824 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 302 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.